536
Views
12
CrossRef citations to date
0
Altmetric
Review

Vaginal progesterone and the vaginal first-pass effect

Pages 355-357 | Received 26 Jan 2018, Accepted 28 Feb 2018, Published online: 27 Mar 2018
 

Abstract

Vaginal progesterone is an effective alternative to systemic administration by oral or intramuscular use. The first-pass effect is reviewed, as are the most common uses for this route of delivery. This includes use in hormone replacement therapy, luteal support particularly in assisted reproduction, and avoidance of side-effects of oral progestins and progesterone. Vaginal progesterone represents a unique therapeutic solution to a number of clinical problems.

Conflict of interest

The author reports no conflict of interest. The author alone is responsible for the content and writing of this paper.

Additional information

Funding

Nil.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.